��������

Robert Campos has extensive work experience in the field of cancer research and therapeutics. Robert started their career in 1994 at Eli Lilly and Company, where they held various roles including Clinical Research Associate, Associate Consultant, and Manager of Endocrine Research and Clinical Investigation. During this time, they were responsible for managing clinical trials and overseeing research operations. In 2012, Campos joined the Ontario Institute for Cancer Research as Senior Director, where they played a vital role in research operations and therapeutic innovation. Robert also served as the Program Director (Interim) for Genomics from 2016 to 2019. Overall, Campos has a strong background in research operations, clinical trials, and strategic decision-making in the field of cancer research.

Robert Campos obtained their Bachelor of Science in Physiology from The University of British Columbia from 1980 to 1984. After that, they pursued a PhD in Physiology from The University of British Columbia from 1985 to 1989. Following their PhD, they completed a Post-Doctoral Fellowship in Molecular Endocrinology at the Banting & Best Diabetes Centre, University of Toronto, from 1989 to 1994. In addition to their educational background, Robert Campos obtained a Six Sigma Black Belt certification in 2005. There is no information provided regarding their education history before attending The University of British Columbia or any other certifications they may have obtained. Furthermore, there are no start or end years provided for their time at De La Salle College 'Oaklands,' nor any degree or field of study specified.